|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Investments: | ||||||||||||||||||||
| Fixed maturity securities at fair value (amortized cost of $45,458 and $44,668, less allowance for credit loss of $63 and $69) | ||||||||||||||||||||
| Equity securities at fair value (cost of $760 and $728) | ||||||||||||||||||||
| Limited partnership investments | ||||||||||||||||||||
| Other invested assets | ||||||||||||||||||||
| Mortgage loans (less allowance for credit loss of $15 and $15) | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Reinsurance receivables (less allowance for uncollectible receivables of $27 and $27) | ||||||||||||||||||||
| Insurance receivables (less allowance for uncollectible receivables of $25 and $25) | ||||||||||||||||||||
| Accrued investment income | ||||||||||||||||||||
| Deferred acquisition costs | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Property and equipment at cost (less accumulated depreciation of $339 and $346) | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Deferred non-insurance warranty acquisition expense | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Insurance reserves: | ||||||||||||||||||||
| Claim and claim adjustment expenses | ||||||||||||||||||||
| Unearned premiums | ||||||||||||||||||||
| Future policy benefits | ||||||||||||||||||||
| Short-term debt | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Deferred non-insurance warranty revenue | ||||||||||||||||||||
| Other liabilities (includes $54 and $54 due to Loews Corporation) | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' Equity | ||||||||||||||||||||
| Common stock ($2.50 par value; 500,000,000 shares authorized; 273,040,243 shares issued; 270,598,685 and 270,671,747 shares outstanding) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Treasury stock (2,441,558 and 2,368,496 shares), at cost | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity |
Loading...
